Your browser doesn't support javascript.
loading
Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis.
Soo, Ross A; Cho, Byoung Chul; Kim, Joo-Hang; Ahn, Myung-Ju; Lee, Ki Hyeong; Zimina, Anastasia; Orlov, Sergey; Bondarenko, Igor; Lee, Yun-Gyoo; Lim, Yueh Ni; Lee, Sung Sook; Lee, Kyung-Hee; Pang, Yong Kek; Fong, Chin Heng; Kang, Jin Hyoung; Lim, Chun Sen; Danchaivijitr, Pongwut; Kilickap, Saadettin; Yang, James Chih-Hsin; Arslan, Cagatay; Lee, Hana; Park, Seong Nam; Cicin, Irfan.
Affiliation
  • Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim JH; CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
  • Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lee KH; Division of Medical Oncology, Department of Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
  • Zimina A; State Budgetary Healthcare Institution of Omsk Region, Omsk, Russia.
  • Orlov S; Pavlov State Medical University, Ulitsa L'va Tolstogo, St. Petersburg, Russia.
  • Bondarenko I; Oncology and Medical Radiology Department, Dnipropetrovsk Medical Academy, Dnipro, Ukraine.
  • Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lim YN; Hospital Umum Sarawak, Jalan Hospital, Kuching, Malaysia.
  • Lee SS; Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
  • Lee KH; Division of Hematology/Oncology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Republic of Korea.
  • Pang YK; University Malaya Medical Centre, University of Malaya, Petaling Jaya, Malaysia.
  • Fong CH; Hospital Pulau Pinang, Pulau Pinang, Malaysia.
  • Kang JH; Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Lim CS; Oncology Department, Hospital Sultan Ismail, Jalan Mutiara Emas Utama, Johor, Malaysia.
  • Danchaivijitr P; Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Kilickap S; Department of Medical Oncology, Istinye University Faculty of Medicine, Liv Hospital Ankara, Ankara, Turkey.
  • Yang JC; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei City, Taiwan.
  • Arslan C; Department of Medical Oncology, Izmir University of Economics Medical Point Hospital, Izmir, Turkey.
  • Lee H; Yuhan Corporation, Seoul, Republic of Korea.
  • Park SN; Yuhan Corporation, Seoul, Republic of Korea.
  • Cicin I; Department of Medical Oncology, Trakya University Medical Center, Edirne, Turkey. Electronic address: irfancicin@hotmail.com.
J Thorac Oncol ; 18(12): 1756-1766, 2023 12.
Article in En | MEDLINE | ID: mdl-37865896
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: J Thorac Oncol Year: 2023 Type: Article Affiliation country: Singapore
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: J Thorac Oncol Year: 2023 Type: Article Affiliation country: Singapore